NCT05514236

Brief Summary

Outpatient hysteroscopy is an essential diagnostic procedure for abnormal uterine bleeding, such as menorrhagia or postmenopausal bleeding, to evaluate any intrauterine pathologies. It also serves as a therapeutic procedure such as removal of fibroids, polyps or intrauterine devices.However, the most common reason for procedure failure is pain. On such occasions, the procedure has to be re-arranged in the operation theatre under regional or general anesthesia. Therefore, improvement in pain management can reduce patients' health care experience, patients' anesthetic and procedural risks, decrease healthcare costs, and reduce inconvenience to patients. This randomized controlled trial aims at evaluating the effectiveness of non-pharmacological interventions (virtual reality and music therapy) in pain management during hysteroscopy. It can hopefully provide more clinical data to explore the role of non-pharmacological techniques in outpatient hysteroscopy pain control, hence help improve our participants' experience in outpatient hysteroscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 24, 2022

Completed
28 days until next milestone

Study Start

First participant enrolled

September 21, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2023

Completed
Last Updated

August 7, 2023

Status Verified

August 1, 2023

Enrollment Period

10 months

First QC Date

August 16, 2022

Last Update Submit

August 3, 2023

Conditions

Keywords

Pain reliefHysteroscopy

Outcome Measures

Primary Outcomes (2)

  • The change of the pain score of virtual reality therapy compared to control group (no intervention) in outpatient hysteroscopy.

    The change of the pain score of virtual reality therapy at different time-point during outpatient hysteroscopy, compared to control group (no intervention). Pain score from 0 to 10, with 0 being no pain and 10 the most severe pain.

    Passage of hysteroscope through cervical internal os and during the assessment of uterine cavity of each participant. The study will be up to 1.5 years.

  • The change of the pain score of music therapy compared to control group (no intervention) in outpatient hysteroscopy.

    The change of the pain score of music therapy at different time-point during outpatient hysteroscopy, compared to control group (no intervention). Pain score from 0 to 10, with 0 being no pain and 10 the most severe pain.

    Passage of hysteroscope through cervical internal os and during the assessment of uterine cavity of each participant. The study will be up to 1.5 years.

Study Arms (3)

Virtual reality group

EXPERIMENTAL

Participants assigned to the Visual reality group will be given the virtual reality device (a headset) with immersive video content for use during the hysteroscopy. Designated moving objects with sound will be broadcasted on the screen to the participant in this group. Participant can adjust the volume of the sound according to her comfort.

Other: Virtual Reality Therapy

Music group

EXPERIMENTAL

Participants in the music group will be given a headphone playing either classical light music or 'POP' songs according to their option during the hysteroscopy. Participant can adjust the volume of the sound according to her comfort.

Other: Music Therapy

Control group

NO INTERVENTION

While participants in the control group will not be given any Virtual reality or music device.

Interventions

Participants will be given the virtual reality device (a headset) with immersive video content for use during the hysteroscopy. Designated moving objects with sound will be broadcasted on the screen to the participant in this group. Participant can adjust the volume of the sound according to her comfort.

Virtual reality group

Participants will be given a headphone playing either classical light music or 'POP' songs according to their option during the hysteroscopy. Participant can adjust the volume of the music according to her comfort.

Music group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants scheduled for outpatient hysteroscopy in Prince of Wales Hospital
  • Participants who are willing to give written consent to participate in the study

You may not qualify if:

  • Participants who have hearing or visual deficits
  • Participants who cannot understand written Chinese
  • Participants refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Agnosia

Interventions

Virtual Reality Exposure TherapyMusic Therapy

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Desensitization, PsychologicBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesSensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient Care

Study Officials

  • KA MAN YiP

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 24, 2022

Study Start

September 21, 2022

Primary Completion

July 5, 2023

Study Completion

July 5, 2023

Last Updated

August 7, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations